2017
TCT-806 12-Month Angiographic and Clinical Follow up of the Fantom Sirolimus-eluting Bioresorbable Scaffold
Bouras G, Abizaid A, Carrie D, Frey N, Lutz M, Weber-Albers J, Dudek D, Chevalier B, Cristea E, Lansky A. TCT-806 12-Month Angiographic and Clinical Follow up of the Fantom Sirolimus-eluting Bioresorbable Scaffold. Journal Of The American College Of Cardiology 2017, 70: b328. DOI: 10.1016/j.jacc.2017.09.1016.Peer-Reviewed Original Research
2012
Impact of Routine Angiographic Follow-Up After Percutaneous Coronary Intervention With Drug-Eluting Stents in the SPIRIT III Randomized Trial at Three Years
Lansky AJ, Brar SS, Yaqub M, Sood P, Applegate RJ, Lazar D, Jankovic I, Hermiller JB, Koo K, Sudhir K, Stone GW. Impact of Routine Angiographic Follow-Up After Percutaneous Coronary Intervention With Drug-Eluting Stents in the SPIRIT III Randomized Trial at Three Years. The American Journal Of Cardiology 2012, 110: 21-29. PMID: 22464212, DOI: 10.1016/j.amjcard.2012.02.040.Peer-Reviewed Original ResearchMeSH KeywordsAngioplasty, Balloon, CoronaryAntineoplastic Agents, PhytogenicCoronary AngiographyCoronary Artery DiseaseEverolimusFollow-Up StudiesHumansImmunosuppressive AgentsPaclitaxelProspective StudiesProsthesis DesignReproducibility of ResultsSingle-Blind MethodSirolimusTime FactorsTreatment OutcomeConceptsPaclitaxel-eluting stentsID-TLRAngiographic groupClinical followMajor adverse cardiovascular event ratesAdverse cardiovascular event ratesDrug-eluting stent placementMajor adverse cardiovascular eventsBare metal stent implantationSPIRIT IIILandmark survival analysisSPIRIT III trialAdverse cardiovascular eventsSafety end pointCardiovascular event ratesIschemia-driven revascularizationMajor clinical outcomesPercutaneous coronary interventionDrug-eluting stentsRoutine AngiographicCardiovascular eventsCoronary revascularizationRevascularization ratesCoronary interventionIII trials
2005
Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis
Silber S, Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Bass T, O'Neill W, Lasala J, Reisman M, Sharma SK, Kuntz RE, Bonan R, Investigators F. Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis. American Heart Journal 2005, 149: 689-694. PMID: 15990754, DOI: 10.1016/j.ahj.2004.05.061.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplasty, Balloon, CoronaryAnticoagulantsBeta ParticlesBrachytherapyCoronary AngiographyCoronary DiseaseCoronary RestenosisDiabetes ComplicationsDisease-Free SurvivalFemaleFollow-Up StudiesHumansLife TablesMaleMiddle AgedPrognosisStentsStrontium RadioisotopesThrombophiliaTreatment OutcomeYttrium RadioisotopesConceptsMajor adverse cardiac eventsTarget vessel revascularizationStent restenosisIntracoronary brachytherapyOriginal patientsPrimary safety end pointTwo-year clinical outcomesPlacebo-controlled randomized trialEnd pointAdverse cardiac eventsPlacebo-controlled studyPrimary end pointSafety end pointKaplan-Meier analysisInitial beneficial effectsRestenosis TrialVessel revascularizationCardiac eventsPlacebo armClinical followActive treatmentClinical outcomesRandomized trialsPlacebo controlPatients
2004
Long term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis
Suntharalingam M, Silber S, Popma J, Speiser B, Lansky A, Teirstein P, Kuntz R, Bonan R. Long term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis. International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s242-s243. DOI: 10.1016/j.ijrobp.2004.07.005.Peer-Reviewed Original ResearchLong term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis
SUNTHARALINGAM M, SILBER S, POPMA J, SPEISER B, LANSKY A, TEIRSTEIN P, KUNTZ R, BONAN R. Long term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis. International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s242-s243. DOI: 10.1016/s0360-3016(04)01268-4.Peer-Reviewed Original Research